Anil K. Sood
Affiliations: | The University of Texas Graduate School of Biomedical Sciences at Houston |
Area:
Cell Biology, Molecular Biology, OncologyGoogle:
"Anil Sood"Children
Sign in to add trainee
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Joseph R, Dasari SK, Umamaheswaran S, et al. (2024) EphA2- and HDAC-Targeted Combination Therapy in Endometrial Cancer. International Journal of Molecular Sciences. 25 |
| Lutgendorf SK, Telles RM, Whitney B, et al. (2023) The biology of hope: Inflammatory and neuroendocrine profiles in ovarian cancer patients. Brain, Behavior, and Immunity |
| Hinchcliff EM, Knisely A, Adjei N, et al. (2023) Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancer. Cancer |
| Corvigno S, Badal S, Spradlin ML, et al. (2023) In situ profiling reveals metabolic alterations in the tumor microenvironment of ovarian cancer after chemotherapy. Npj Precision Oncology. 7: 115 |
| Zhang X, Yao J, Li X, et al. (2023) Targeting polyploid giant cancer cells potentiates a therapeutic response and overcomes resistance to PARP inhibitors in ovarian cancer. Science Advances. 9: eadf7195 |
| Foster KI, Shaw KRM, Jin J, et al. (2023) Clinical implications of tumor-based next-generation sequencing in high-grade epithelial ovarian cancer. Cancer |
| Dasari SK, Joseph R, Umamaheswaran S, et al. (2023) Combination of EphA2- and Wee1-Targeted Therapies in Endometrial Cancer. International Journal of Molecular Sciences. 24 |
| Glassman D, Kim MS, Spradlin M, et al. (2023) Exploiting metabolic vulnerabilities after anti-VEGF antibody therapy in ovarian cancer. Iscience. 26: 106020 |
| Ruiz M, Zhang N, Sood AK, et al. (2022) Antibody therapeutics for epithelial ovarian cancer. Expert Opinion On Biological Therapy. 1-13 |
| Handley KF, Sims TT, Bateman NW, et al. (2022) Classification of High-Grade Serous Ovarian Cancer Using Tumor Morphologic Characteristics. Jama Network Open. 5: e2236626 |